Sponsors (10)
The resolution preserves no‑cost access to Task Force‑recommended preventive services and keeps federal evidence‑review structures in place, but funding cuts, potential politicization, and meeting delays risk weakening the quality, timeliness, and public trust in preventive guidance.
People with private insurance, Medicare, or Medicaid keep access to Task Force A/B recommended preventive services (e.g., screenings, vaccinations) without deductible or copay, reducing out‑of‑pocket cost barriers.
Clinicians, hospitals, and health systems retain an evidence‑based, transparent USPSTF recommendation process they can rely on, supporting more consistent preventive care delivery and likely better patient outcomes.
State governments and health systems preserve federal capacity (AHRQ and Evidence‑based Practice Centers) for high‑quality evidence reviews that inform preventive care recommendations and policy.
Patients with chronic conditions and health systems face weaker and slower evidence reviews because reduced AHRQ funding and staffing can diminish the Task Force’s capacity to update and maintain high‑quality recommendations.
Patients and providers risk politicized preventive guidance because Secretary of HHS appointment/removal and review authority could influence member selection or recommendations, undermining public trust.
Medicare and Medicaid beneficiaries (and others relying on timely guidance) may experience delays in covered preventive services because canceled or postponed Task Force meetings can postpone evidence consideration and updated recommendations.
Based on analysis of 2 sections of legislative text.
Records and affirms the USPSTF’s role, notes AHRQ support and recent resource cuts, cites a Supreme Court ruling, and documents a canceled July 10, 2025 Task Force meeting.
Introduced July 29, 2025 by Angus Stanley King · Last progress July 29, 2025
Recognizes the U.S. Preventive Services Task Force (USPSTF) as an independent, evidence‑based panel that issues clinical preventive service recommendations and notes that the Affordable Care Act requires insurers to cover USPSTF A and B recommendations without cost‑sharing. It identifies the Agency for Healthcare Research and Quality (AHRQ) as the Task Force’s administrative support and expresses concern about recent AHRQ funding and staffing reductions. Notes the Supreme Court decision affirming the Task Force’s statutory status and the Secretary of HHS’s appointment/removal/review authority, records the Task Force’s typical March/July/November meeting schedule, and documents that the HHS Secretary canceled the July 10, 2025 meeting on July 7, 2025 — raising potential concerns about timing of recommendations and administrative continuity.